CDTX stock forecast
Our latest prediction for Cidara Therapeutics, Inc.'s stock price was made on the Sept. 24, 2019 when the stock price was at 1.87$.
In the short term (2weeks), CDTX's stock price should outperform the market by 7.61%. During that period the price should oscillate between -9.78% and +19.98%.
In the medium term (3months), CDTX's stock price should outperform the market by 13.38%. During that period the price should oscillate between -22.08% and +50.57%.Get email alerts
About Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
At the moment the company generates 19M USD in revenues.
On its last earning announcement, the company reported a loss of -1.49$ per share.
The book value per share is 2.97$
Three months stock forecastSept. 24, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|